SciClone Pharmaceuticals is a venture capital fund that invests in early-stage health tech and biotech companies. They offer financial support with modest-sized checks to help young companies grow. Notable investments include Ability Pharmaceuticals. With a background as a US-based, China-focused pharmaceutical company, SciClone has expertise in oncology, infectious diseases, and heart health. Their goal is to support businesses advancing healthcare and medical science.
